支链氨基酸转氨酶1调控胶质母细胞瘤细胞可塑性并促进免疫抑制
研究利用人类肿瘤数据、细胞系模型及原位免疫健全与免疫缺陷小鼠模型,探讨BCAT1对胶质母细胞瘤细胞状态和免疫调节的表型与机制效应。结果显示BCAT1维持肿瘤细胞低分化状态,其敲除促进分化并减弱免疫抑制,使CD8+细胞毒性T细胞广泛浸润并完全抑制肿瘤生长。
要点
- BCAT1对维持胶质母细胞瘤细胞低分化状态至关重要,其低表达与更分化的表型相关。
- 免疫健全小鼠原位注射显示脑微环境足以诱导Bcat1-KO肿瘤体内分化。
- Bcat1敲除减弱免疫抑制,促进CD8+细胞毒性T细胞浸润并完全抑制肿瘤生长。
核心结论
- BCAT1通过抑制肿瘤细胞分化和维持免疫抑制微环境促进胶质母细胞瘤生长,靶向抑制BCAT1为胶质母细胞瘤提供了新的治疗途径。
研究设计与样本
- 研究使用人类肿瘤数据、细胞系模型以及原位免疫健全和免疫缺陷小鼠模型,探究BCAT1对胶质母细胞瘤细胞状态和免疫调节的表型与机制效应。
主要发现
- BCAT1对维持胶质母细胞瘤细胞低分化状态至关重要,其低表达与更分化的胶质母细胞瘤表型相关。
- 免疫健全小鼠原位肿瘤注射显示脑微环境足以诱导Bcat1-KO肿瘤体内分化。
- 向分化细胞状态的转变与十十一易位去甲基化酶活性增加及神经元分化基因低甲基化和激活相关。
- Bcat1敲除减弱免疫抑制,允许CD8+细胞毒性T细胞广泛浸润并完全抑制肿瘤生长。
- 免疫缺陷小鼠进一步分析显示,BCAT1-KO后肿瘤细胞分化和免疫调节均 contribute 于肿瘤生长的长期抑制。
临床怎么用
- 作者认为这些发现为通过抑制BCAT1靶向治疗胶质母细胞瘤提供了新的治疗途径。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a fast relapse of the tumors following treatment. Moreover, the immunosuppressive microenvironment proved to be a major obstacle to immunotherapeutic approaches. Branched-chain amino acid transaminase 1 (BCAT1) was shown to drive the growth of glioblastoma and other cancers;however, its oncogenic mechanism remains poorly understood. METHODS: Using human tumor data, cell line models and orthotopic immuno-competent and -deficient mouse models, we investigated the phenotypic and mechanistic effects of BCAT1 on glioblastoma cell state and immunomodulation. RESULTS: Here, we show that BCAT1 is crucial for maintaining the poorly differentiated state of glioblastoma cells and that its low expression correlates with a more differentiated glioblastoma phenotype. Furthermore, orthotopic tumor injection into immunocompetent mice demonstrated that the brain microenvironment is sufficient to induce differentiation of Bcat1-KO tumors in vivo. We link the transition to a differentiated cell state to the increased activity of ten-eleven translocation demethylases and the hypomethylation and activation of neuronal differentiation genes. In addition, the knockout of Bcat1 attenuated immunosuppression, allowing for an extensive infiltration of CD8+ cytotoxic T-cells and complete abrogation of tumor growth. Further analysis in immunodeficient mice revealed that both tumor cell differentiation and immunomodulation following BCAT1-KO contribute to the long-term suppression of tumor growth. CONCLUSIONS: Our study unveils BCAT1's pivotal role in promoting glioblastoma growth by inhibiting tumor cell differentiation and sustaining an immunosuppressive milieu. These findings offer a novel therapeutic avenue for targeting glioblastoma through the inhibition of BCAT1.
引用
- Boskovic P, Wilke N, Man KH, et al. Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression. Neuro Oncol. 2024. PMID: 37769206. doi:10.1093/neuonc/noad190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。